A Single Dose Study of SHR0410 in Healthy Male Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a randomized, double-blind, placebo-controlled, single ascending-dose study to investigate the effect of a single intravenous (IV) dose of SHR0410 at 6 dose levels (0.5 μg/kg, 1 μg/kg, 2 μg/kg, 5 μg/kg, 10 μg/kg and 20 μg/kg) in healthy participants.
Epistemonikos ID: 7e9eb3288e26cfb0f47db7f1c2619d3bb0714162
First added on: May 21, 2024